论文部分内容阅读
目的:探析手术为主的综合治疗运用在Ⅲ期非小细胞肺癌中的临床效果。方法:本组选择2010年3月至2011年3月期间收治的Ⅲ期非小细胞肺癌患者56例为研究对象,根据数字随机表法将其分为两组,其中给予对照组放化疗治疗,而观察组在胸腔镜手术治疗的基础上,联合放化疗治疗,比较两组治疗效果。结果:与对照组比较,观察组的治疗有效率较高,组间对比差异明显(P<0.05);两组不良反应发生率比较无明显差异(P>0.05);同时,随访1~5年,观察组的1年、3年以及5年生存率均较高,组间比较差异显著(P<0.05)。结论:临床上给予Ⅲ期非小细胞肺癌患者手术为主的综合治疗,不仅可以降低不良反应发生率,还能提高远期生存率,值得推广。
Objective: To investigate the clinical effect of comprehensive operation-based therapy in stage Ⅲ non-small cell lung cancer. Methods: 56 cases of stage Ⅲ non-small cell lung cancer who were treated in our hospital from March 2010 to March 2011 were selected as the research object. According to the digital random table method, they were divided into two groups. The patients in the control group received radiotherapy and chemotherapy, The observation group on the basis of thoracoscopic surgery, combined with radiotherapy and chemotherapy, the treatment effect was compared. Results: Compared with the control group, the treatment group had a higher effective rate of treatment and the difference between the two groups was significant (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05) . The 1-year, 3-year and 5-year survival rates in the observation group were all higher than those in the observation group (P <0.05). CONCLUSIONS: The comprehensive treatment of patients with stage III non-small cell lung cancer clinically can not only reduce the incidence of adverse reactions, but also improve the long-term survival rate, which deserves promotion.